New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For A;R;SPW;SNY;WBMD;CVS;ESV;TER;BSX From The Last 14 Days
Check below for free stories on A;R;SPW;SNY;WBMD;CVS;ESV;TER;BSX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
September 22, 2014
07:21 EDTSNYEBD Group to hold a conference
Subscribe for More Information
September 19, 2014
07:22 EDTCVSNational Press Club holds a luncheon meeting
Subscribe for More Information
September 18, 2014
11:55 EDTCVSRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
September 17, 2014
18:29 EDTAOn The Fly: After Hours Movers
Subscribe for More Information
17:01 EDTAAgilent board approves separation of Keysight, declares special dividend
Subscribe for More Information
16:57 EDTAAgilent creates new group for services, consumables
Subscribe for More Information
16:55 EDTAAgilent announces Mike McMullen to succeed Bill Sullivan as CEO in March 2015
Subscribe for More Information
07:43 EDTBSXBofA/Merrill to hold a conference
Subscribe for More Information
06:18 EDTSNYSanofi, MyoKardia announce collaboration
Subscribe for More Information
05:09 EDTBSXBoston Scientific receives CE Mark for Vercise DBS system
Subscribe for More Information
September 16, 2014
07:58 EDTBSXBoston Scientific product still likely to get nod despite data, says Wells Fargo
Although new data presented at TCT showed that the confirmatory PREVAIL study of Boston Scientific's Watchman device missed both co-primary efficacy endpoints, Wells Fargo still thinks there is a 60%-70% chance of an FDA panel recommending approval of the device on October 8. Wells keeps an Outperform rating on the stock.
07:33 EDTSNYMylan initiates Phase III clinical trials for Advair Diskus and Lantus
Mylan (MYL) announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's (GKS) Advair Diskus and its insulin analog to Sanofi's (SNY) Lantus. In October Mylan will commence a Phase III clinical trial to evaluate the equivalence of its product to Advair Diskus when administered by inhalation in adult asthma patients.
07:26 EDTRUltima Media to hold a conference
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use